Clinical Trials Logo

Filter by:
NCT ID: NCT03239327 Recruiting - Clinical trials for Neonatal Respiratory Distress

Vaginal Misoprostol to Improve the Neonatal Respiratory Outcome

Start date: June 2016
Phase: N/A
Study type: Interventional

Project summary: Objective: To test the hypothesis that administration of vaginal Misoprostol before elective cesarean section will improve the neonatal respiratory outcomes in late preterm and early term neonates through induction of catecholamine surge. Design: Randomized controlled clinical trial. Setting: Women health center ,Assiut university hospital. Patients: mothers planned for cesarean section at 34 - 37weeks. Intervention: two hundred and ninety two women will be randomly allocated to receive either 50 micrograms of Misoprostol per vagina within one hour before cesarean section (study group; n= 146) or receive nothing (control group; n = 146) . Main outcome measure: Apgar score at 1 and 5 minutes.

NCT ID: NCT03235921 Recruiting - Hemorrhagic Shock Clinical Trials

Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock

Start date: March 2016
Phase: Phase 2
Study type: Interventional

Hemorrhagic shock is a pathologic state in which intravascular volume and oxygen delivery are impaired. During circulatory failure associated with hypovolemia and low cardiac output, redistribution of blood flow caused by increased vasoconstriction results in decreased perfusion of the skin. Skin temperature and capillary refill time has been advocated as a measure of peripheral perfusion.

NCT ID: NCT03235648 Recruiting - Ovarian Cancer Clinical Trials

Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Evaluation of surgical excision of cardiophrenic lymph nodes in patients with advanced ovarian cancer

NCT ID: NCT03234517 Recruiting - Clinical trials for Bacterial Vaginosis Treatment

Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis

Start date: August 1, 2016
Phase: Phase 2
Study type: Interventional

Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis

NCT ID: NCT03233880 Recruiting - Pre-Eclampsia Clinical Trials

Impact of Antichlamydial Treatment on the Rate of Preeclampsia

Start date: July 1, 2016
Phase: Phase 4
Study type: Interventional

This randomized, double blinded controlled trial included 1200 healthy primigravidae who attended an outpatient clinic at 16-20weeks of pregnancy. All women were randomly divided equally into two groups, group A(600 women) who received antichlamydial treatment in the form of azithromycin 1 gram single oral dose before 20 weeks of pregnancy and group B (600 women) who received no treatment(placebo). All participants were followed up for up to 6 weeks postpartum and observed for the development of preeclampsia.

NCT ID: NCT03230162 Recruiting - Clinical trials for Fetal Growth Restriction

Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

Start date: June 1, 2017
Phase: Phase 3
Study type: Interventional

comparing the effect of using sildenafil citrate and LMWH in treatment of cases of IUGR due to placental insufficiency

NCT ID: NCT03224780 Recruiting - Placenta Accreta Clinical Trials

Creatine Kinase Versus 3D Doppler for Antenatal Diagnosis of Abnormal Adherent Placenta.

Start date: June 1, 2017
Phase:
Study type: Observational

Placenta accreta is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management.Diagnosis of placenta accreta before delivery minimizes potential maternal or neonatal morbidity and mortality. In this study the researchers will evaluate the role and cost effectiveness of biochemical marker as creatine kinase in comparison with 3D Doppler ultrasound in antenatal diagnosis of placenta accreta and its variants in patients with placenta previa totalis.

NCT ID: NCT03220685 Recruiting - Clinical trials for Gut Micrbota and Its Relation to Anemia of CKD Patients

Relationship Between Gut Microbiota And Anemia In Patients With Chronic Renal Failure

Start date: June 25, 2019
Phase:
Study type: Observational

The human intestinal tract harbours a diverse and complex microbial community which plays a central role in human health. It has been estimated that our gut contains in the range of 1000 bacterial species and 100-fold more genes than are found in the human genome . This community is commonly referred to as our hidden metabolic 'organ' due to their immense impact on human wellbeing, including host metabolism, physiology, nutrition and immune function. It is now apparent that our gut microbiome coevolves with us and that changes to this population can have major consequences, both beneficial and harmful, for human health. Indeed, it has been suggested that disruption of the gut microbiota (or dysbiosis) can be significant with respect to pathological intestinal conditions such as obesity and malnutritio, systematic diseases such as diabetes and chronic inflammatory diseases such as inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD) . The role of the gut microbiome in human health and disease is becoming clearer thanks to high throughput sequencing technologies (HTS) as well as parallel recent developments in non genomic techniques.

NCT ID: NCT03220503 Recruiting - Infertility Clinical Trials

Effect of Endometrial Injury Before Frozen Embryo Transfer on Pregnancy Rate

Start date: March 8, 2017
Phase: Phase 4
Study type: Interventional

Research Question: In women undergoing frozen embryo transfer, does routine endometrial injury before frozen embryo transfer increase clinical pregnancy rate? Research Hypothesis: (Null Hypothesis) In women undergoing frozen embryo transfer Routine endometrial injury before frozen embryo transfer does not increase clinical pregnancy rate. (Alternative Hypothesis) In women undergoing frozen embryo transfer, endometrial injury before the transfer may increase pregnancy rate.

NCT ID: NCT03218943 Recruiting - Clinical trials for Ventilation Therapy; Complications

Physiological Dead Space Measured by Volumetric Capnography in BiPAP and APRV .

Start date: August 25, 2017
Phase: N/A
Study type: Interventional

Background and Rationale : Mechanical ventilation is an essential component of the care of patients with respiratory failure.Biphasic positive Airway Pressure (BiPAP) and Airway Pressure release ventilation (APRV) are relatively new modes of mechanical ventilation which can be used in treatment of patients with impaired oxygenation.The effect of using BiPAP and APRV modes on reducing the physiological dead space had not been previously investigated. The investigators hypothesize that using APRV mode will decrease physiological dead space more than BiPAP mode in the mechanically ventilated critically ill patients. Objectives : To assess the physiological dead space with each mode. To assess lung mechanics during the use of the two modes. To assess the effectiveness of ventilation during the use of the two modes. Study population & Sample size : Sixty adult patients more than 18 years old who are mechanically ventilated patients with P/F ratio less than 300. This sample size was calculated based on the assumption that APRV will decrease dead space by 20% with alpha error 0.05 and power 80%. The mean and Standard deviation of the volume of the dead space assessed in a previous study using BIPAP was 40 Study Design : A randomized controlled non-blinded study with cross-over design. In the Trauma and surgical ICU at 185-Hospital (Kasr Alainy Hospitals). Methods : All mechanically ventilated patients in Trauma and surgical ICU at 185-Hospital (Kasr Alainy Hospitals) will start on pressure controlled ventilation mode (PCV) with inspiratory pressure achieving tidal volume 6-8 ml/kg for 2 hours then they will be randomized into one of the two study groups the BIPAP group or the APRV group . Possible Risk (s) to study population : By adjusting the ventilator parameters properly and continuous monitoring of the patients in the study, there will be no risk facing the patients. Outcome parameter (s): Primary outcome: Physiological dead space will be measured in the two groups after 30 minutes. Secondary outcomes - Physiological dead space after 3 hours. - PO2/FiO2 ratio. - Peak airway and Mean airway pressures. - PCO2 and PH. - Dynamic compliance.